aiwiki.page
English
Health / Medicine & Treatment / radical-prostatectomy

Radical prostatectomy

Radical prostatectomy is surgery to remove the entire prostate and seminal vesicles, primarily to treat prostate cancer confined to the prostate or nearby tissues.

22 keywords2 linked from3 not yet writtenWritten by AI
SurgeryProstateProstate cancerMetastasisBiopsyCancer StagingMagnetic Resonan…Radiation Therap…Radical pr…

Radical prostatectomy is a surgical operation that removes the entire prostate gland and seminal vesicles, primarily as a potentially curative treatment for prostate cancer. Nearby pelvic lymph nodes may also be removed. After the prostate is removed, the bladder is reconnected to the urethra to restore the passage of urine. The term radical describes the extent of tissue removal; it does not imply that the cancer is necessarily advanced or that cure is guaranteed.

Purpose and clinical context

Radical prostatectomy is principally used for cancer that appears confined to the prostate and for selected cancers extending into nearby tissues. In some higher-risk cases, it forms part of treatment that also includes radiation or systemic therapy. It is not generally a standard curative treatment for cancer with distant metastases.

The suitability of surgery depends on the cancer’s extent and biological aggressiveness, as well as the individual’s general health, expected longevity, and preferences. Assessment commonly includes the prostate-specific antigen level, findings from biopsy, tumor grade, and clinical stage. Magnetic resonance imaging helps assess local anatomy and tumor extent; additional imaging may be used when the risk of spread warrants it.

Other management approaches include radiation therapy and, for appropriately selected lower-risk cancers, active surveillance. Active surveillance involves structured monitoring with treatment if findings indicate progression or increased risk. It differs from watchful waiting, which generally focuses on managing symptoms rather than preserving an opportunity for curative treatment. These alternatives make shared decision-making important: cancer control, urinary function, sexual function, and treatment burden can carry different importance for different individuals.

Radical prostatectomy is distinct from operations for benign prostatic hyperplasia. Simple prostatectomy and transurethral procedures remove or reduce obstructing prostate tissue but leave substantial portions of the gland behind; they are not equivalent cancer operations.

Anatomy and operative principles

The prostate lies below the bladder and surrounds the upper urethra. The seminal vesicles lie behind the bladder and contribute fluid to semen. Structures important to urinary continence and erectile function lie close to the prostate, making their preservation a central technical concern.

The main operative steps are:

  • Separating the prostate and seminal vesicles from surrounding tissues.
  • Dividing the connection between the bladder and prostate and the urethra below the gland.
  • Removing the surgical specimen.
  • Joining the bladder neck to the remaining urethra, creating a vesicourethral anastomosis.

A urinary catheter temporarily drains the bladder while this connection heals. The duration of catheterization varies with the operation and postoperative findings.

Nerve-sparing surgery

Nerves involved in erections run alongside the prostate within neurovascular bundles. Nerve-sparing surgery attempts to preserve these structures on one or both sides when this is compatible with adequate cancer removal.

Nerve sparing does not guarantee preservation of erections. Recovery also depends on preoperative function, age, other illnesses, and the extent of surgical injury. When cancer is suspected close to or beyond the prostate boundary, wider tissue removal may be necessary.

Pelvic lymph-node dissection

Removal of pelvic lymph nodes can establish whether cancer has spread to regional nodes and provide information relevant to subsequent treatment. It is not necessary in every case; its use depends on the estimated risk of nodal involvement.

Lymph-node dissection adds potential complications, including lymph-filled collections called lymphoceles and, less commonly, persistent lymphedema. Its staging value is established, whereas the extent to which it independently improves cancer survival remains uncertain.

Surgical approaches

Radical prostatectomy can be performed through several approaches:

Approach Main characteristics
Open retropubic Uses an incision in the lower abdomen and allows access to pelvic lymph nodes through the same operative field.
Open perineal Uses an incision between the scrotum and anus; pelvic lymph-node assessment generally requires separate access.
Laparoscopic Uses small incisions, a camera, and long instruments.
Robot-assisted laparoscopic Uses a surgeon-controlled robotic system to manipulate instruments through small incisions.

Robot-assisted surgery is not autonomous: the surgeon controls the instruments. It has become widely used in many health systems.

Compared with open surgery, laparoscopic and robot-assisted approaches generally reduce blood loss and may shorten hospitalization. However, an approach alone does not establish superior long-term cancer control, continence, or sexual function. Outcomes also depend on patient selection, surgical technique, operator experience, and how results are measured. Studies comparing approaches may be affected by differences in these factors.

Pathological assessment and follow-up

The removed tissue undergoes histopathological examination. The report establishes or refines several features:

  • Tumor grade, commonly expressed using the Gleason score and Grade Group.
  • Whether cancer extends beyond the prostate.
  • Whether the seminal vesicles or sampled lymph nodes contain cancer.
  • Whether cancer cells reach the inked edge of the specimen, termed a positive surgical margin.

A positive margin indicates an increased risk of recurrence but does not mean that recurrence is inevitable. Conversely, a negative margin does not exclude microscopic disease elsewhere.

Prostate-specific antigen (PSA) is central to follow-up. Because the prostate produces most circulating PSA, the level is expected to fall to very low or undetectable levels after complete removal. A persistently detectable or subsequently rising PSA can indicate residual or recurrent cancer.

Biochemical recurrence refers to recurrence defined by PSA findings rather than necessarily by symptoms or visible disease. Definitions and confirmation requirements vary between clinical settings and studies. A rising PSA does not by itself establish where the cancer is located or whether distant spread has occurred.

Further treatment may include radiation to the prostate bed or pelvic region, sometimes combined with hormone-directed treatment. Treatment given because of adverse pathological findings before evidence of recurrence is termed adjuvant treatment; treatment initiated for evidence of persistent or recurrent disease is termed salvage treatment. These strategies differ in timing, intended benefit, and the risk of treating people who might not otherwise develop clinically important recurrence.

Complications and functional effects

Perioperative complications

Potential early complications include bleeding, infection, blood clots, urine leakage at the bladder–urethra connection, and injury to adjacent structures such as the rectum or ureters. Serious complications are uncommon but can occur with any approach. The procedure also carries risks associated with anesthesia.

Later complications include scar-related narrowing at the bladder–urethra connection or within the urethra. Such narrowing can obstruct urine flow and sometimes requires further procedures.

Urinary continence

Urinary incontinence is an important postoperative effect. Leakage is often most pronounced soon after catheter removal and may improve over subsequent months. Stress incontinence—leakage with coughing, lifting, or exertion—is a characteristic pattern, although urgency-related symptoms can also occur.

Some individuals have persistent leakage. Reported continence rates differ substantially because studies use different definitions, such as no pads, one security pad, or patient-reported absence of troublesome leakage. Management of persistent incontinence can include pelvic-floor rehabilitation and, in selected cases, devices such as a male sling or artificial urinary sphincter.

Sexual function and fertility

Erectile dysfunction can result from nerve injury, vascular changes, and other effects of surgery. Recovery, when it occurs, may take many months or longer. Published recovery rates depend strongly on baseline function, nerve preservation, follow-up duration, and whether erections achieved with medication or devices are counted.

Removal of the prostate and seminal vesicles eliminates normal semen emission, resulting in a dry orgasm. Orgasmic sensation may remain, although its intensity or character can change. Other possible effects include urine leakage during orgasm and changes in perceived penile length.

Natural conception through intercourse is no longer possible after radical prostatectomy. Sperm production in the testes may continue, so biological parenthood can sometimes remain possible through previously stored sperm or sperm retrieval combined with assisted reproduction.

Outcomes and interpretation of evidence

Radical prostatectomy can provide durable cancer control, especially for appropriately selected localized disease, but outcomes vary substantially with grade, stage, PSA level, and other tumor characteristics. Some patients require additional treatment despite apparently complete removal.

Long-term comparative studies show that treatment benefits depend on the population studied and the time horizon. Results from cancers detected before widespread PSA testing do not necessarily apply directly to contemporary screen-detected disease. Likewise, older active-monitoring protocols are not identical to modern active surveillance.

Evaluation therefore extends beyond survival or PSA recurrence to urinary and sexual function, treatment burden, and health-related quality of life. Differences in baseline health, follow-up, outcome definitions, and use of additional treatment must be considered when comparing published surgical results.